Donate Now Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Capital Hilton

Oct 28, 2024 8:30 AM - Oct 30, 2024 12:40 PM

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

CONTACT US

Send Email 1.888.257.6457

CONTACT US

Send Email 1.888.257.6457

Agenda

Day 1 Oct 28, 2024

11:00 AM — 12:30 PM

Session 2 Track 3: Regulatory Experiences with Clinical/ Commercial Oligonucleotides

1:30 PM — 3:00 PM

Session 3 Track 3: Emerging Oligonucleotide CMC Guidance

3:30 PM — 4:45 PM

Session 4 Track 3: Demonstrating Comparability for Oligonucleotides Therapeutics

Day 2 Oct 29, 2024

10:00 AM — 11:30 AM

Session 6 Track 3: CMC Considerations in Development of mRNA-based Therapeutics

12:45 PM — 2:15 PM

Session 7 Track 3: Challenges Around Oligonucleotides Control Strategies

Day 3 Oct 30, 2024

8:00 AM — 9:15 AM

Session 9 Track 3: Innovative Manufacturing Approaches and Regulatory Implications

9:25 AM — 10:40 AM

Session 10 Track 3: Streamlining Oligonucleotide Development with Platform Approaches Roundtable

Have an account?